Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1/2 5Phase NA 4Phase 1 3Phase 3 2Phase EARLY_PHASE1 1

Status

Unknown 5

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Non-Small-Cell Lung 699Breast Neoplasms 629Neoplasms 582Leukemia, Myeloid, Acute 481Colorectal Neoplasms 455Multiple Myeloma 444Melanoma 424Prostatic Neoplasms 383Neoplasm Metastasis 370Pancreatic Neoplasms 361Recurrence 347Lymphoma 340Ovarian Neoplasms 322Lung Neoplasms 297Lymphoma, Non-Hodgkin 295Leukemia 287Glioblastoma 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Stomach Neoplasms 246Leukemia, Lymphocytic, Chronic, B-Cell 235Carcinoma, Hepatocellular 231Squamous Cell Carcinoma of Head and Neck 219Lymphoma, Large B-Cell, Diffuse 217Myelodysplastic Syndromes 212Carcinoma, Renal Cell 210Lymphoma, Follicular 183Head and Neck Neoplasms 172Brain Neoplasms 169Triple Negative Breast Neoplasms 167Lymphoma, Mantle-Cell 167

Interventions

surufatinib 1Oxaliplatin 1Irinotecan 1Folfox protocol 1Fluorouracil 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Advanced Colorectal Cancer × Clear all
NCT02826837 2021-10-06

LEAC-102 for Advanced Colorectal Cancer

Taiwan Leader Biotech Corp.

Phase 1/2 Unknown
30 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT05035914 2021-09-05

Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer

Guangzhou University of Traditional Chinese Medicine

Phase 1/2 Unknown
94 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT04929652 2021-06-18

Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer

Jiangsu Cancer Institute & Hospital

Phase 1/2 Unknown
48 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT04337879 2020-07-21

A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Unknown
56 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT00854971 2009-05-18

Efficacy Study of TKcell in Advanced Colorectal Cancer

Binex

Phase 1/2 Unknown
86 enrolled
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡